More hope for cancer-afflicted patients on anvil
June 23rd, 2008
The NABĂ‚Â technology is being tested in some other cancers like lung cancer and pancreatic cancer. In other cases, where credible breakthrough has lacked, experts are using a combination of anti-cancer drugs to increase their efficacy. Novartis’ Zometa and Glaxos’ Tykerb is being tried with other drugs that has showed almost 36% more survival in chronic breast cancer patients.